Received Dec 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
patient accidentally received 3 doses of SHINGRIX; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date) and Shingrix (received 2nd dose on an unknown date). On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: patient accidentally received 3 doses of SHINGRIX). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date 22-DEC-2025 The reporter stated that a patient accidentally received 3 doses of Shingrix. She did not provide any patient information. The batch number was not provided, and we are unable to contact the reporter